Loading...

Stefanie Ueda, MD

TitleAssociate Professor
InstitutionUniversity of California San Francisco
DepartmentOb/Gyn, Reproductive Sciences
Address550 16th. Street
San Francisco CA 94158
Phone415-885-7561
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    New York UniversityM.D.2002Medicine
    University of HawaiiResidency2006Obstetrics & Gynecology
    Johns Hopkins School of MedicineFellowship2010Gynecologic Oncology

    Collapse Overview 
    Collapse Overview
    Dr. Stefanie Ueda joined the UCSF faculty in 2010, helping to expand outreach services in the North Bay in gynecologic malignancies and serving to develop an educational exchange and surgical training program in Uganda. She has collaborated with Duke University to start the first in country gynecologic oncology fellowship in Uganda to expand cancer care and women's health services in sub-Saharan Africa. The fellowship has gained official recognition and sponsorship from both the Society of Gynecologic Oncology and the International Gynecologic Cancer Society in 2018.


    Collapse ORNG Applications 
    Collapse Clinical Trials
    Collapse Websites

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Sethi R, Mayadev J, Sethi S, Rash D, Chen LM, Brooks R, Ueda S, Hsu IC. Patterns of Recurrence in Node Positive Cervical Cancer Patients Treated with Contemporary Chemoradiation and Dose Escalation: A Multi-Institutional Study. Pract Radiat Oncol. 2018 Oct 17. PMID: 30342181.
      View in: PubMed
    2. Koh WJ, Abu-Rustum NR, Bean S, Bradley K, Campos SM, Cho KR, Chon HS, Chu C, Cohn D, Crispens MA, Damast S, Dorigo O, Eifel PJ, Fisher CM, Frederick P, Gaffney DK, George S, Han E, Higgins S, Huh WK, Lurain JR, Mariani A, Mutch D, Nagel C, Nekhlyudov L, Fader AN, Remmenga SW, Reynolds RK, Tillmanns T, Ueda S, Wyse E, Yashar CM, McMillian NR, Scavone JL. Uterine Neoplasms, Version 1.2018, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2018 Feb; 16(2):170-199. PMID: 29439178.
      View in: PubMed
    3. Swanson M, Ueda S, Chen LM, Huchko MJ, Nakisige C, Namugga J. Evidence-based improvisation: Facing the challenges of cervical cancer care in Uganda. Gynecol Oncol Rep. 2018 May; 24:30-35. PMID: 29892691.
      View in: PubMed
    4. Koh WJ, Greer BE, Abu-Rustum NR, Campos SM, Cho KR, Chon HS, Chu C, Cohn D, Crispens MA, Dizon DS, Dorigo O, Eifel PJ, Fisher CM, Frederick P, Gaffney DK, Han E, Higgins S, Huh WK, Lurain JR, Mariani A, Mutch D, Nagel C, Nekhlyudov L, Fader AN, Remmenga SW, Reynolds RK, Tillmanns T, Ueda S, Valea FA, Wyse E, Yashar CM, McMillian N, Scavone J. Vulvar Cancer, Version 1.2017, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2017 01; 15(1):92-120. PMID: 28040721.
      View in: PubMed
    5. Chapman JS, Roddy E, Ueda S, Brooks R, Chen LL, Chen LM. Enhanced Recovery Pathways for Improving Outcomes After Minimally Invasive Gynecologic Oncology Surgery. Obstet Gynecol. 2016 07; 128(1):138-44. PMID: 27275797.
      View in: PubMed
    6. Chapman JS, Asthana S, Cade L, Chang MT, Wang Z, Zaloudek CJ, Ueda S, Collisson EA, Taylor BS. Clinical Sequencing Contributes to a BRCA-Associated Cancer Rediagnosis That Guides an Effective Therapeutic Course. J Natl Compr Canc Netw. 2015 Jul; 13(7):835-45. PMID: 26150578.
      View in: PubMed
    7. Fuh KC, Shin JY, Kapp DS, Brooks RA, Ueda S, Urban RR, Chen LM, Chan JK. Survival differences of Asian and Caucasian epithelial ovarian cancer patients in the United States. Gynecol Oncol. 2015 Mar; 136(3):491-7. PMID: 25455734.
      View in: PubMed
    8. Usach I, Blansit K, Chen LM, Ueda S, Brooks R, Kapp DS, Chan JK. Survival differences in women with serous tubal, ovarian, peritoneal, and uterine carcinomas. Am J Obstet Gynecol. 2015 Feb; 212(2):188.e1-6. PMID: 25149685.
      View in: PubMed
    9. Simons E, Blansit K, Tsuei T, Brooks R, Ueda S, Kapp DS, Chan JK. Foreign- vs US-born Asians and the association of type I uterine cancer. Am J Obstet Gynecol. 2015 Jan; 212(1):43.e1-6. PMID: 25043758.
      View in: PubMed
    10. Fader AN, Java J, Ueda S, Bristow RE, Armstrong DK, Bookman MA, Gershenson DM. Survival in women with grade 1 serous ovarian carcinoma. Obstet Gynecol. 2013 Aug; 122(2 Pt 1):225-32. PMID: 23969788; PMCID: PMC4870595.
    11. Yu X, Lum D, Kiet TK, Fuh KC, Orr J, Brooks RA, Ueda SM, Chen LM, Kapp DS, Chan JK. Utilization of and charges for robotic versus laparoscopic versus open surgery for endometrial cancer. J Surg Oncol. 2013 May; 107(6):653-8. PMID: 23129514.
      View in: PubMed
    12. Cohen JG, Kiet T, Shin JY, Sherman AE, Hamilton CA, Brooks RA, Ueda SM, Chen LM, Kapp DS, Chan JK. Factors associated with publication of plenary presentations at the Society of Gynecologic Oncologists annual meeting. Gynecol Oncol. 2013 Jan; 128(1):128-31. PMID: 22892364.
      View in: PubMed
    13. Giuntoli RL, Gerardi MA, Yemelyanova AV, Ueda SM, Fleury AC, Diaz-Montes TP, Bristow RE. Stage I noninvasive and minimally invasive uterine serous carcinoma: comprehensive staging associated with improved survival. Int J Gynecol Cancer. 2012 Feb; 22(2):273-9. PMID: 22146771.
      View in: PubMed
    14. Bristow RE, Ueda S, Gerardi MA, Ajiboye OB, Ibeanu OA. Analysis of racial disparities in stage IIIC epithelial ovarian cancer care and outcomes in a tertiary gynecologic oncology referral center. Gynecol Oncol. 2011 Aug; 122(2):319-23. PMID: 21632099.
      View in: PubMed
    15. Skaznik-Wikiel ME, Ueda SM, Frasure HE, Rose PG, Fleury A, Grumbine FC, Fader AN. Abnormal cervical cytology in the diagnosis of uterine papillary serous carcinoma: earlier detection of a poor prognostic cancer subtype? Acta Cytol. 2011; 55(3):255-60. PMID: 21525737.
      View in: PubMed
    16. Krill LS, Ueda SM, Gerardi M, Bristow RE. Analysis of postoperative complications associated with the use of anti-adhesion sodium hyaluronate-carboxymethylcellulose (HA-CMC) barrier after cytoreductive surgery for ovarian, fallopian tube and peritoneal cancers. Gynecol Oncol. 2011 Feb; 120(2):220-3. PMID: 21145096.
      View in: PubMed
    17. Ueda SM, Yap KL, Davidson B, Tian Y, Murthy V, Wang TL, Visvanathan K, Kuhajda FP, Bristow RE, Zhang H, Shih IeM. Expression of Fatty Acid Synthase Depends on NAC1 and Is Associated with Recurrent Ovarian Serous Carcinomas. J Oncol. 2010; 2010:285191. PMID: 20508725; PMCID: PMC2873657.
    18. Ueda SM, Mao TL, Kuhajda FP, Vasoontara C, Giuntoli RL, Bristow RE, Kurman RJ, Shih IeM. Trophoblastic neoplasms express fatty acid synthase, which may be a therapeutic target via its inhibitor C93. Am J Pathol. 2009 Dec; 175(6):2618-24. PMID: 19893031; PMCID: PMC2789637.
    19. Barlin JN, Ueda SM, Bristow RE. Cytoreductive surgery for advanced and recurrent endometrial cancer: a review of the literature. Womens Health (Lond). 2009 Jul; 5(4):403-11. PMID: 19586432.
      View in: PubMed
    20. Veras E, Mao TL, Ayhan A, Ueda S, Lai H, Hayran M, Shih IeM, Kurman RJ. Cystic and adenofibromatous clear cell carcinomas of the ovary: distinctive tumors that differ in their pathogenesis and behavior: a clinicopathologic analysis of 122 cases. Am J Surg Pathol. 2009 Jun; 33(6):844-53. PMID: 19342944.
      View in: PubMed
    21. Bristow RE, Peiretti M, Gerardi M, Zanagnolo V, Ueda S, Diaz-Montes T, Giuntoli RL, Maggioni A. Secondary cytoreductive surgery including rectosigmoid colectomy for recurrent ovarian cancer: operative technique and clinical outcome. Gynecol Oncol. 2009 Aug; 114(2):173-7. PMID: 19482344.
      View in: PubMed
    22. Chan JK, Ueda SM, Sugiyama VE, Stave CD, Shin JY, Monk BJ, Sikic BI, Osann K, Kapp DS. Analysis of phase II studies on targeted agents and subsequent phase III trials: what are the predictors for success? J Clin Oncol. 2008 Mar 20; 26(9):1511-8. PMID: 18285603.
      View in: PubMed
    23. Ueda SM, Kapp DS, Cheung MK, Shin JY, Osann K, Husain A, Teng NN, Berek JS, Chan JK. Trends in demographic and clinical characteristics in women diagnosed with corpus cancer and their potential impact on the increasing number of deaths. Am J Obstet Gynecol. 2008 Feb; 198(2):218.e1-6. PMID: 18226630.
      View in: PubMed